Plus Therapeutics, Inc. Made Headway

Plus Therapeutics, Inc. (PSTV:NASDAQ) shot up at $2.8, representing a gain of 25.6%. On Thu 04 Mar 21, PSTV:NASDAQ touched a New 2-Week Low of $2.23. The stock appeared on our News Catalysts scanner on Fri 05 Mar 21 at 04:56 PM in the 'INSIDER' category. From Thu 18 Feb 21, the stock recorded 30.00% Up Days and 27.27% Green Days

The stock spiked on Wed 10 Feb 21 at $5.42 with a volume of 15M+.

About Plus Therapeutics, Inc. (PSTV:NASDAQ)

Cytori Therapeutics Inc is a specialty therapeutics company. It focuses to provide meaningful and quality therapeutic options with a broad utility that benefit patients and healthcare providers. The company has two therapeutic development platforms: Cytori Cell Therapy (CCT) and Cytori Nanomedicine. The CCT platform is based on the scientific discovery that the human adipose or fat tissue compartment is a source of a mixed population of stem, progenitor and regenerative cells. The Cytori Nanomedicine Platform features a versatile and novel protein-stabilized liposomal nanoparticle technology for drug encapsulation that provides the foundation to bring two drugs into early/ late-stage clinical trials.